Shai Lankry
Vermögen: 994 $ am 30.06.2026
Vermögen: 994 $ am 30.06.2026
Shai Lankry currently works at Purple Biotech Ltd., as Chief Financial Officer from 2025.
Mr. Lankry also formerly worked at West Pharmaceutical Services, Inc., as Finance Director from 2016 to 2018, Omrix Biopharmaceuticals, Inc., as Finance Director-Biologics Cluster from 2015 to 2016, Kesselman & Kesselman, as Senior Associate, PricewaterhouseCoopers (Israel), as Senior Associate, Gamida Cell Ltd., as Vice President-Finance in 2023, and Macrocure Ltd., as Chief Financial Officer from 2016 to 2017.
Mr. Lankry received his Masters Business Admin degree from Tel-Aviv University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PURPLE BIOTECH LTD. 0,01 % | 18.03.2026 | 295.833 ( 0,01 % ) | 994 $ | 30.06.2026 |
| 12.05.25 | Purple Biotech ernennt Shai Lankry zum CFO | RE |
| Unternehmen | Position | Beginn |
|---|---|---|
| PURPLE BIOTECH LTD | Finanzdirektor/CFO | 12.05.2025 |
| Unternehmen | Position | Ende |
|---|---|---|
| GAMIDA CELL LTD. | Finanzdirektor/CFO | 22.05.2023 |
| WEST PHARMACEUTICAL SERVICES, INC. | Finanzdirektor/CFO | 01.01.2018 |
| MACROCURE LTD | Finanzdirektor/CFO | 01.01.2017 |
Omrix Biopharmaceuticals, Inc.
Omrix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops biosurgical and immunotherapy solutions | Corporate Officer/Principal | 01.01.2016 |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Omrix Biopharmaceuticals, Inc.
Omrix Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops biosurgical and immunotherapy solutions | Health Technology |
Kesselman & Kesselman
Kesselman & Kesselman Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PricewaterhouseCoopers (Israel)
PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Gamida Cell Ltd.
Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Macrocure Ltd.
Macrocure Ltd. Medical SpecialtiesHealth Technology Develops a novel therapeutic platform to address chronic and hard-to-heal wounds, such as diabetic foot ulcers and venous leg ulcers | Health Technology |
Purple Biotech Ltd.
Purple Biotech Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drug discovery and development services | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen